Sorafenib-induced erythema multiforme: three cases

Eur J Dermatol. 2011 Nov-Dec;21(6):1015-6. doi: 10.1684/ejd.2011.1535.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Renal Cell / secondary
  • Drug-Related Side Effects and Adverse Reactions / etiology*
  • Erythema Multiforme / chemically induced*
  • Erythema Multiforme / pathology
  • Female
  • Humans
  • Kidney Neoplasms / pathology
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein Kinase Inhibitors / adverse effects*
  • Pyridines / adverse effects*
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Niacinamide
  • Sorafenib